Cargando…
Chasing COVID-19 through SARS-CoV-2 spike glycoprotein
An ongoing pandemic Coronavirus disease (COVID-19), caused by a newly emerged Coronavirus, SARS-CoV-2 has affected millions of people globally. One of the most crucial structural proteins of SARS-CoV-2 is the Spike glycoprotein (S-glycoprotein), for which the first de novo modelling was envisaged by...
Autores principales: | Saxena, Shailendra K., Kumar, Swatantra, Baxi, Preeti, Srivastava, Nishant, Puri, Bipin, Ratho, R. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718591/ https://www.ncbi.nlm.nih.gov/pubmed/33313362 http://dx.doi.org/10.1007/s13337-020-00642-7 |
Ejemplares similares
-
Global Trends in Epidemiology of Coronavirus Disease 2019 (COVID-19)
por: Srivastava, Nishant, et al.
Publicado: (2020) -
Therapeutic approaches for SARS-CoV-2 infection
por: Gupta, Ankur, et al.
Publicado: (2021) -
Recombinant vaccines for COVID-19
por: Yadav, Tushar, et al.
Publicado: (2020) -
Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor
por: Maurya, Vimal K., et al.
Publicado: (2020) -
Structural and molecular perspectives of SARS-CoV-2
por: Kumar, Swatantra, et al.
Publicado: (2021)